Description
⋅ IPCA LABS is on a strong footing and is well placed to capitalize on the growth
opportunities across the domestic and export markets.
It is expected that the stock will see a price target of Rs.1814 in 8 to 10 months time frame on average P/E of 29x and
FY21 (E) earnings of Rs.62.56.